Suppr超能文献

一例免疫功能正常成年人侵袭性感染后噬血细胞性淋巴组织细胞增生症的病例报告

A Case Report of Aggressive Post-Infectious Hemophagocytic Lymphohistiocytosis in an Immunocompetent Adult.

作者信息

Theik Nyein Wint Yee

机构信息

Internal Medicine, Memorial Healthcare System, Pembroke Pines, USA.

出版信息

Cureus. 2023 Dec 30;15(12):e51334. doi: 10.7759/cureus.51334. eCollection 2023 Dec.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is an acute inflammatory syndrome triggered by immune events such as infections, inflammation, autoimmune diseases, and malignancies. Initial presentations can range from vague symptoms to infectious features such as fever. Given its aggressive nature, timely diagnosis and immediate treatment are crucial to achieving optimal patient outcomes. Recently, the HLH score (HScore) criteria have been applied as diagnostic criteria, offering a broader scope compared to the previous HLH-2004 score, which was primarily based on pediatric populations. The standard treatment for decades has involved the combination of etoposide and high-dose steroids, and it is recommended to initiate treatment as soon as possible, even in the absence of a bone marrow test or when there is suspicion of the diagnosis. In this case presentation, we aim to underscore the significance of maintaining a high level of suspicion for HLH and the importance of promptly initiating treatment.

摘要

噬血细胞性淋巴组织细胞增生症(HLH)是一种由感染、炎症、自身免疫性疾病和恶性肿瘤等免疫事件引发的急性炎症综合征。最初的表现可能从模糊症状到发热等感染性特征不等。鉴于其侵袭性,及时诊断和立即治疗对于实现最佳患者预后至关重要。最近,HLH评分(HScore)标准已被用作诊断标准,与之前主要基于儿科人群的HLH-2004评分相比,其涵盖范围更广。几十年来的标准治疗一直是依托泊苷和高剂量类固醇联合使用,即使在没有骨髓检查或怀疑诊断的情况下,也建议尽快开始治疗。在本病例报告中,我们旨在强调对HLH保持高度怀疑的重要性以及及时开始治疗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e9e/10824277/96b0a2131ce5/cureus-0015-00000051334-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验